Differences among human immunodeficiency virus strains in their capacities to induce cytolysis or persistent infection of a lymphoblastoid cell line immortalized by Epstein-Barr virus
about
Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causationPathogenesis of human immunodeficiency virus infectionThe expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT proteinEffect of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine on establishment of human immunodeficiency virus type 1 infection in cultured CD8+ lymphocytesGeneration of hybrid human immunodeficiency virus by homologous recombination.Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency.Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats.Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1A hard way to the nucleusPhenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell linesEvaluation of human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T-lymphocyte responses utilizing B-lymphoblastoid cell lines transduced with the CD4 gene and infected with HIV-1.Human transformed trophoblast-derived cells lacking CD4 receptor exhibit restricted permissiveness for human immunodeficiency virus type 1.Isolation and partial characterization of infectious molecular clones of feline immunodeficiency virus obtained directly from bone marrow DNA of a naturally infected catPersistent nonproductive infection of Epstein-Barr virus-transformed human B lymphocytes by human immunodeficiency virus type 1.Epstein-Barr virus-positive and -negative B-cell lines can be infected with human immunodeficiency virus types 1 and 2.Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies.Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individualDistinct replicative and cytopathic characteristics of human immunodeficiency virus isolates.Human immunodeficiency virus induction of malignant transformation in human B lymphocytes.Differential diagnosis of human retrovirus infections in the laboratory.Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.Increased Virus Replication and Cytotoxicity of Non-pathogenic Simian Human Immuno Deficiency Viruses-NM-3rN After Serial Passage in a Monkey-Derived Cell Line.Similar replication capacities of primary human immunodeficiency virus type 1 isolates derived from a wide range of clinical sources.Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection.
P2860
Q24627627-94079E82-4C1F-4EB0-8A6F-69FB3B9B8B40Q24634681-666BE8C8-99B1-4EBE-8E35-ECB18C11FBE2Q24680024-EFC729CC-BE05-4CF9-85FC-C473E9B0E86EQ28369395-198F3468-BB03-492D-A765-059B92F1CBC8Q34298463-07867F96-03FB-4DE9-94E9-3525BF2C1E68Q35832979-029E9302-F9BA-4823-AF0F-41A8A08D9E22Q35860257-3551B4E7-588C-4E7F-A08D-BD57B41186A7Q35882940-F786B805-0D21-4244-84DF-4CD0B851A501Q35926911-74D86188-B7D4-4348-AC72-0EA0E114B82BQ36355185-7D333AE9-5C48-4045-9D29-E275BFD6224DQ36625106-926879B9-4532-4590-913E-454BDCAE4BDCQ36684585-9CA8597A-4676-403A-996A-7BBF7C2711B5Q36690700-9E4031EA-4EC5-41AB-98D8-24F76A7FE0C2Q36804062-5488DA92-DCC9-4E17-BBC6-E7765A9E056CQ36872675-EDC8D261-6660-4545-9D94-4382212727E7Q36878009-DDEDA3B1-AA7E-45D4-ABA3-FB5633F25D23Q36881607-FBEDF436-D079-482E-AD00-E9ADDF649538Q36882975-148D9DD3-388A-480E-8336-20FEF493E0E5Q37585854-5504AC7C-F5D4-4347-8404-93BFD3B9E28DQ38286541-F471ABE9-FD0C-478F-B443-9DB0413CA480Q38319697-0EAC27D7-013D-49B1-AD76-542E3C6543C3Q39157862-48E5364A-326E-4614-B9D0-4B4341690C8EQ40049097-BB8A19A0-BB74-43C1-9EE7-EB4BEE211474Q40128160-0F77A6B3-1A53-4751-A1A3-CC377DF52593Q40175608-86635C8F-2EE8-4E9D-9376-193F24A0F21F
P2860
Differences among human immunodeficiency virus strains in their capacities to induce cytolysis or persistent infection of a lymphoblastoid cell line immortalized by Epstein-Barr virus
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Differences among human immuno ...... rtalized by Epstein-Barr virus
@en
type
label
Differences among human immuno ...... rtalized by Epstein-Barr virus
@en
prefLabel
Differences among human immuno ...... rtalized by Epstein-Barr virus
@en
P2093
P2860
P1433
P1476
Differences among human immuno ...... rtalized by Epstein-Barr virus
@en
P2093
P2860
P304
P407
P577
1987-05-01T00:00:00Z